Myriad Genetics
(NASDAQ:MYGN)
$25.47
0.22[0.87%]
At close: May 10
$25.47
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Tue May 7th, after the market close
The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast

Myriad Genetics Stock (NASDAQ:MYGN), Earnings Estimates, EPS, and Revenue

Myriad Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 7
EPS
$-0.010
Quarterly Revenue
$202.2M
Annual Revenue
(as of Dec 31)
$753.2M

Analyze the earnings history of Myriad Genetics using advanced sorting and filters.

No data available to display
ticker
▲▼
Company Name
▲▼
Prior EPS
▲▼
Est EPS
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Prior Rev
▲▼
Est Rev
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Date
▲▼
Get Alert

FAQ

Q

When is Myriad Genetics (NASDAQ:MYGN) reporting earnings?

A

Myriad Genetics (MYGN) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Myriad Genetics (NASDAQ:MYGN)?

A

The Actual EPS was $-0.01, which beat the estimate of $-0.10.

Q

What were Myriad Genetics’s (NASDAQ:MYGN) revenues?

A

The Actual Revenue was $202.2M, which beat the estimate of $193.3M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch